2 news items
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting
CHRS
8 Apr 24
an investigational new drug (IND) application in Q2 2024 and begin clinical studies later this year. About Coherus BioSciences
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
CHRS
13 Mar 24
, 2024, in San Diego.Coherus plans to file an Investigational New Drug (IND) application in second quarter of 2024
- Prev
- 1
- Next